Posted On: 05/12/2016 6:14:36 PM
Post# of 223
BioPharmX Corp.
On May 11, 2016, James Pekarsky, Chief Executive Officer, Treasurer and a member of the Board of Directors (the “Board”) of BioPharmX Corporation (the “Company”) informed the Board of his decision to resign from these roles and his employment at the Company, effective on May 11, 2016. Mr. Pekarsky’s resignation from the Board was not due to any disagreement with the Company on any matter relating to its operations, policies or practices. A copy of Mr. Pekarsky’s letter of resignation addressed to the Board is attached as Exhibit 99.1 to this report. On May 12, 2016, the Company issued a press release announcing Mr. Pekarsky’s decision to resign. A copy of the press release is attached as Exhibit 99.2 to this report.
On May 11, 2016, James Pekarsky, Chief Executive Officer, Treasurer and a member of the Board of Directors (the “Board”) of BioPharmX Corporation (the “Company”) informed the Board of his decision to resign from these roles and his employment at the Company, effective on May 11, 2016. Mr. Pekarsky’s resignation from the Board was not due to any disagreement with the Company on any matter relating to its operations, policies or practices. A copy of Mr. Pekarsky’s letter of resignation addressed to the Board is attached as Exhibit 99.1 to this report. On May 12, 2016, the Company issued a press release announcing Mr. Pekarsky’s decision to resign. A copy of the press release is attached as Exhibit 99.2 to this report.
(0)
(0)
